Form 4: Akamai Technologies Executive Kim Salem-Jackson Reports Stock Transactions
SEC Form 4 Filing
EVP, Chief Marketing Officer of Akamai Technologies, Kim Salem-Jackson, reports the vesting and disposal of restricted stock units.
Summary
- Kim Salem-Jackson, EVP, Chief Marketing Officer of Akamai Technologies, reported transactions involving Akamai common stock on March 7, 2025.
- These transactions included the vesting of 2,857 restricted stock units (RSUs) and the disposal of 1,382 shares to cover tax obligations at a price of $82.81 per share.
- Following these transactions, Salem-Jackson directly owns 56,732 shares of Akamai common stock and indirectly owns 57.33 shares through a 401(k) plan as of March 4, 2025.
- The RSUs were granted on March 7, 2022, and vest in equal installments over three years.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice for publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they represent a small fraction of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/07/2022 | Ms. Salem-Jackson was granted 8,570 RSUs which vest over three years. |
| 03/04/2025 | As of this date, Ms. Salem-Jackson indirectly owns 57.33 shares through a 401(k) Plan. |
| 03/07/2025 | Date of reported transactions: vesting of RSUs and disposal of shares. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.